A detailed history of Group One Trading, L.P. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Group One Trading, L.P. holds 2,383 shares of CDXC stock, worth $8,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,383
Previous 11,179 78.68%
Holding current value
$8,459
Previous $38,000 84.21%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.44 - $4.32 $21,462 - $37,998
-8,796 Reduced 78.68%
2,383 $6,000
Q1 2024

May 10, 2024

BUY
$1.36 - $3.84 $6,120 - $17,280
4,500 Added 67.38%
11,179 $38,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $1.6 $5,032 - $6,291
3,932 Added 143.14%
6,679 $9,000
Q3 2023

Nov 09, 2023

SELL
$1.36 - $1.77 $13,600 - $17,700
-10,000 Reduced 78.45%
2,747 $4,000
Q2 2023

Aug 09, 2023

BUY
$1.31 - $1.79 $16,698 - $22,817
12,747 New
12,747 $20,000
Q3 2022

Nov 09, 2022

SELL
$1.19 - $2.06 $4,760 - $8,240
-4,000 Reduced 10.4%
34,458 $42,000
Q2 2022

Aug 11, 2022

BUY
$1.59 - $2.7 $7,244 - $12,301
4,556 Added 13.44%
38,458 $64,000
Q1 2022

May 12, 2022

BUY
$2.02 - $3.92 $29,447 - $57,145
14,578 Added 75.44%
33,902 $83,000
Q4 2021

Feb 11, 2022

SELL
$3.74 - $6.7 $210,348 - $376,828
-56,243 Reduced 74.43%
19,324 $72,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $1.04 Million - $1.79 Million
-171,948 Reduced 69.47%
75,567 $474,000
Q2 2021

Aug 10, 2021

SELL
$6.66 - $10.92 $2.47 Million - $4.05 Million
-371,247 Reduced 60.0%
247,515 $2.44 Million
Q1 2021

May 12, 2021

BUY
$4.59 - $18.74 $2.84 Million - $11.6 Million
618,762 New
618,762 $5.78 Million
Q2 2020

Aug 13, 2020

SELL
$3.0 - $5.52 $82,626 - $152,031
-27,542 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$2.83 - $4.61 $77,943 - $126,968
27,542 New
27,542 $119,000
Q4 2017

Feb 09, 2018

SELL
$3.88 - $6.96 $15,520 - $27,840
-4,000 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$2.91 - $4.71 $11,640 - $18,840
4,000
4,000 $17,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $243M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.